how to administer ghk-cu peptide Copper GHK-Cu Topical Copper Peptide Serum

Citing significant, unresolved safety risks, a total lack of robust human clinical efficacy data, and grave concerns over immunogenicity and peptide-related impurities, the FDA officially designated 19 of the most popular therapeutic peptidesexplicitly including BPC-157, TB-500 (Thymosin beta-4 fragment), and injectable GHK-Cuas Category 2 bulk drug substances

Mechanism of Action Copper-binding tripeptide that activates tissue remodeling genes, promotes collagen and glycosaminoglycan synthesis, stimulates angiogenesis, and modulates metalloproteinase activity to coordinate wound healing and anti-inflammatory responses

Pregnancy and lactation safety has not been systematically studied, and as with most cosmetic and research compounds lacking definitive pregnancy safety data, conservative practice typically suggests avoiding use during pregnancy unless clearly needed, though the natural occurrence of GHK-Cu in the body and minimal systemic absorption from topical use suggest risk is likely to be low

Its ability to modulate the hepatocyte growth factor (HGF)/c-Met system provides a functional platform for exploring molecular events underlying cognitive processes